Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHumacyte Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.19 | -$0.08 | -$0.12 |
| Q2 2026 | 3 | -$0.12 | -$0.09 | -$0.11 |
| Q3 2026 | 1 | -$0.18 | -$0.08 | -$0.11 |
| Q4 2026 | 1 | -$0.16 | -$0.07 | -$0.10 |
| Q1 2027 | 1 | -$0.10 | -$0.04 | -$0.06 |
| Q2 2027 | 1 | -$0.10 | -$0.04 | -$0.06 |
| Q3 2027 | 1 | -$0.09 | -$0.04 | -$0.05 |
| Q4 2027 | 1 | -$0.08 | -$0.03 | -$0.05 |
| Q1 2028 | 1 | $0.35 | $0.82 | $0.50 |
| Q2 2028 | 1 | $0.37 | $0.86 | $0.53 |
| Q3 2028 | 1 | $0.36 | $0.84 | $0.51 |
| Q4 2028 | 1 | $0.36 | $0.85 | $0.52 |
Humacyte Inc Earnings Date And Information
Humacyte Inc last posted its earnings results on Wednesday, May 13th, 2026. The company reported $-0.09 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.01. The company had revenue of 495.00 K for the quarter and had revenue of 2.04 M for the year. Humacyte Inc has generated $0 earnings per share over the last year ($-0.26 diluted earnings per share) and currently has a price-to-earnings ratio of -2.29. Humacyte Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Humacyte Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2026 | Q1 2026 | -$0.10 | -$0.09 | 0.01 | $1.46 M | $495.00 K |
| 03/27/2026 | Q4 2025 | -$0.13 | -$0.15 | -0.02 | $1.35 M | $467.00 K |
| 11/12/2025 | Q3 2025 | -$0.17 | -$0.11 | 0.06 | $922.83 K | $753.00 K |
| 08/11/2025 | Q2 2025 | -$0.15 | -$0.24 | -0.09 | $1.00 M | $301.00 K |
| 05/13/2025 | Q1 2025 | -$0.19 | $0.28 | 0.47 | $764.83 K | $517.00 K |
| 03/31/2025 | Q4 2024 | N/A | -$0.16 | N/A | $214.29 K | $7.23 M |
| 11/08/2024 | Q3 2024 | -$0.26 | -$0.33 | -0.07 | $300.00 K | $0 |
| 08/13/2024 | Q2 2024 | -$0.23 | -$0.48 | -0.25 | $20.00 K | $0 |
| 05/13/2024 | Q1 2024 | N/A | -$0.29 | N/A | $20.00 K | $0 |
| 03/28/2024 | Q4 2023 | N/A | -$0.24 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.25 | -$0.25 | 0 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$0.22 | -$0.22 | 0 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$0.22 | -$0.60 | -0.38 | N/A | $0 |
| 03/24/2023 | Q4 2022 | -$0.24 | $0.13 | 0.37 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.21 | -$0.25 | -0.04 | N/A | $31.00 K |
| 08/12/2022 | Q2 2022 | -$0.22 | $0.36 | 0.58 | N/A | $1.30 M |
| 05/13/2022 | Q1 2022 | -$0.21 | -$0.16 | 0.05 | N/A | $233.00 K |
| 03/29/2022 | Q4 2021 | -$0.19 | $0.41 | 0.6 | N/A | $177.00 K |
| 11/12/2021 | Q3 2021 | N/A | -$0.72 | N/A | N/A | $241.00 K |
| 08/16/2021 | Q2 2021 | -$0.56 | -$0.17 | 0.39 | N/A | $690.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Humacyte Inc Earnings: FAQ's
In the previous quarter, Humacyte Inc (:HUMA) reported $-0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.01.
The conference call for Humacyte Inc's latest earnings report can be listened to online.
The conference call transcript for Humacyte Inc's latest earnings report can be read online.
Humacyte Inc (:HUMA) has a recorded annual revenue of $2.04 M.
Humacyte Inc (:HUMA) has a recorded net income of $-40,833,000.Humacyte Inc has generated $-0.26 earnings per share over the last four quarters.
Humacyte Inc (:HUMA) has a price-to-earnings ratio of -2.29 and price/earnings-to-growth ratio is 0.01.